IntelliProve
IntelliProve secured €2.7M in seed funding to continue development of its health sensing layer technology for any camera, including humanoids.
Get news, papers, media and research delivered. Sign up for our free newsletters.
Stay up-to-date with news and resources you need to do your job. Research industry trends, compare companies and get weekly market intelligence with Robotics 24/7.
IntelliProve
IntelliProve secured €2.7M in seed funding to continue development of its health sensing layer technology for any camera, including humanoids.
Belgian healthtech company IntelliProve announced a €2.7 million seed funding round.
The company, which said it is building the health sensing layer for any camera, said that it will bring that layer from virtual care to humanoid robots.
IntelliProve said that Miles Ahead led the funding round, with Wit-Gele Kruis, imec.istart and several business angels taking part.
People pick up their phone or open their laptop many times a day. Until now, IntelliProve said that those devices could tell them nothing about their own health without a separate device such as a blood pressure cuff or a wearable.
IntelliProve said that it is now adding that layer. The company said that a user can look into the camera for 30 seconds and get six scientifically validated biomarkers back:
IntelliProve said that the partner keeps its own app and brand, and because the added layer is software, it is not tied to one device: it works with a standard camera, in a smartphone or laptop today and in a humanoid robot next.
“Healthcare is at a tipping point. We believe the future of health monitoring is software-first, scalable and accessible to everyone,” said Joeri Tulkens, co-founder and co-CEO of IntelliProve. “Our virtual care partners are not just experimenting with IntelliProve, they are building it into the core of their offering. Humanoid robots are next: they are becoming very good at understanding the world around them, and the next step is helping them understand the people within that world. This funding lets us make IntelliProve the health sensing layer for any camera, worldwide.”
The company said that the science behind its technology is called remote photoplethysmography, or rPPG. Every heartbeat pushes blood through the face and changes the color of the skin very slightly: invisible to the eye, but measurable by a camera. From those tiny changes, and from the small movements of breathing, IntelliProve said that the software can read heart rate, HRV, breathing and blood pressure, without touching the person.
The company said that quality control, signal extraction and cuffless blood pressure measurement are the most challenging aspects of camera-based measurements, and precisely what IntelliProve has focused on with its in-house R&D.
As the software maps the skin and follows it as the person moves, IntelliProve said that it pulls a clean blood pulse signal from the face. Vital signs, such as systolic and diastolic blood pressure, are derived from the shape of the pulse wave with the deep learning model that the company developed in-house.
To ensure quality and accuracy, IntelliProve said that there’s a continuous three-level quality gate during the scan: on the video, the signal and the final values. IntelliProve said that it built each of these in-house as three proprietary technologies: VitalMesh, TripleGate and PulseShape.
The company said that its R&D team has authored and co-authored several peer-reviewed research papers and its models are tested and validated on more than 6 million data points. The company works with academic and healthcare partners including TU Delft, Ghent University Hospital and Wit-Gele Kruis.
Today, the company said that its ISO 27001-certified technology runs in virtual care, health insurance and wellbeing platforms around the world. Now, IntelliProve said that it is taking it further on two fronts: CE marking as a Class IIa medical device under the EU Medical Device Regulation and bringing the same health sensing layer to new devices with a camera, starting with humanoid robots.
IntelliProve said that humanoid robots are moving from controlled industrial environments into homes and care facilities. They already use cameras to see and navigate, and can tell that a person is standing in front of them, but not how that person is doing. IntelliProve said that it provides that missing layer: with those same cameras, a robot can offer the person it assists a 30-second scan of heart rate, breathing rate and blood pressure, without additional measurement hardware.
In elderly care, the company said that this technology gives carers extra context about a resident; at home, health information becomes available without anyone having to operate a separate device. The robot passes the values on; a person interprets them and decides what happens next. The ambition is not to replace human care, but to extend its reach where care capacity is limited.
IntelliProve said that it is already working with selected robotics partners and will use the funding to expand these partnerships internationally, bringing the layer to the makers of humanoid and assistive robots and to the companies building their perception and software stacks.
“Opening our technology to new devices doesn't change the standards we set for the technology itself,” said Tanguy Sanglet, co-founder and CTO of IntelliProve. “We will keep investing heavily in research, scientific validation and high-quality data, and we want our layer certified in markets around the world. Whether the scan runs on a smartphone or on a humanoid robot, the bar stays the same: the best health sensing layer in the world.”
IntelliProve said that the funding strengthens the health sensing layer on three fronts: technology, certification and reach.
“IntelliProve has built its face scan technology with virtual care platforms in more than 50 countries,” said Luc Burgelman, founder of Miles Ahead. “The company has developed a unique technology with a clear focus on scientific validation and certification. It’s now ready to scale at large with a meaningful impact on millions of lives, and that’s why we are leading this round.”
Enjoyed this article? Add Robotics 24/7 as a preferred source in Google Search.
Colette Kress, current EVP and CFO of NVIDIA named interim CEO
China's Office of the Working Mechanism for Foreign Investment Security…
President Trump orders a review of robotics imports over national security…
Platform helps robots adapt to complex tasks